These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11099155)

  • 61. Involvement of chemical mediators in nasal allergic responses of HDC-KO mice.
    Rahman MA; Inoue T; Ishikawa T; Yatsuzuka R; Ohtsu H; Kamei C
    Eur J Pharmacol; 2007 Jul; 567(3):245-51. PubMed ID: 17543300
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intranasal therapy with CpG DNA alone for the control of allergic rhinitis.
    Suzuki M; Nakamura Y; Matsumoto T; Yokota M; Ohno N; Murakami S
    Adv Otorhinolaryngol; 2011; 72():113-5. PubMed ID: 21865706
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA-133b Ameliorates Allergic Inflammation and Symptom in Murine Model of Allergic Rhinitis by Targeting Nlrp3.
    Xiao L; Jiang L; Hu Q; Li Y
    Cell Physiol Biochem; 2017; 42(3):901-912. PubMed ID: 28662502
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The Orai1 antibody treatment for a mouse model of allergic rhinitis].
    Lin L; Dai F; Sun T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 51(1):43-9. PubMed ID: 26791768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
    Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model.
    Mo JH; Kang EK; Quan SH; Rhee CS; Lee CH; Kim DY
    Allergy; 2011 Feb; 66(2):279-86. PubMed ID: 21208219
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice.
    Kayasuga R; Iba Y; Hossen MA; Watanabe T; Kamei C
    Int Immunopharmacol; 2003 Apr; 3(4):469-73. PubMed ID: 12689652
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The role of sinomenine in treatment of allergic rhinitis mice model and its mechanism].
    Chen Z; Tao Z; Zhang N; Ren J; Deng Y; Xiao B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 27(2):81-4. PubMed ID: 23650707
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Systemic administration of olygodeoxynucleotides with CpG motifs at priming phase reduces local Th2 response and late allergic rhinitis in BALB/c mice.
    Hayashi T; Hasegawa K; Sasaki Y
    Inflammation; 2008 Feb; 31(1):47-56. PubMed ID: 17849181
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intranasal immunization with phosphorylcholine suppresses allergic rhinitis in mice.
    Miyashita K; Ohori J; Nagano H; Fukuyama S; Kurono Y
    Laryngoscope; 2018 Jul; 128(7):E234-E240. PubMed ID: 29193138
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An essential role for dendritic cells in human and experimental allergic rhinitis.
    KleinJan A; Willart M; van Rijt LS; Braunstahl GJ; Leman K; Jung S; Hoogsteden HC; Lambrecht BN
    J Allergy Clin Immunol; 2006 Nov; 118(5):1117-25. PubMed ID: 17088138
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis.
    Mo JH; Park SW; Rhee CS; Takabayashi K; Lee SS; Quan SH; Kim IS; Min IY; Raz E; Lee CH
    Am J Rhinol; 2006; 20(2):212-8. PubMed ID: 16686392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of local nasal immunotherapy on nasal blockage in pollen-induced allergic rhinitis of Guinea pigs.
    Nabe T; Kubota K; Mizutani N; Fujii M; Terada T; Takenaka H; Kohno S
    Allergol Int; 2008 Dec; 57(4):419-27. PubMed ID: 18946238
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early decrease in nasal eosinophil proportion after nasal allergen challenge correlates with baseline bronchial reactivity to methacholine in children sensitized to house dust mites.
    Silvestri M; Battistini E; Defilippi AC; Sabatini F; Sale R; Pecora S; Rossi GA
    J Investig Allergol Clin Immunol; 2005; 15(4):266-76. PubMed ID: 16433208
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Experimental allergic rhinitis-related cough and airway eosinophilia in sensitized guinea pigs.
    Brozmanova M; Bartos V; Plank L; Tatar M
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):57-65. PubMed ID: 18204116
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Establishment of a new animal model of allergic rhinitis with biphasic sneezing by intranasal sensitization with Staphylococcal enterotoxin B.
    Sun R; Tang X; Yao H; Hong S; Yang Y; Kou W; Wei P
    Exp Ther Med; 2015 Aug; 10(2):407-412. PubMed ID: 26622329
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of dietary nucleosides and nucleotides on murine allergic rhinitis.
    Almansouri HM; Yamamoto S; Kulkarni AD; Ariizumi M; Adjei AA; Yamauchi K
    Am J Med Sci; 1996 Nov; 312(5):202-5. PubMed ID: 8900381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of anti-VLA-4 monoclonal antibody treatment in murine model of allergic rhinitis.
    Matsui T; Asakura K; Shirasaki H; Sato J; Himi T
    Acta Otolaryngol; 2000 Sep; 120(6):761-5. PubMed ID: 11099155
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of CD4-positive T cells in the pathogenesis of nasal allergy in the murine model.
    Ogasawara H; Asakura K; Saito H; Kataura A
    Int Arch Allergy Immunol; 1999 Jan; 118(1):37-43. PubMed ID: 9925961
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sex-related differences in the initiation of allergic rhinitis in mice.
    Yamatomo T; Okano M; Ono T; Nakayama E; Yoshino T; Satoskar AR; Harn DA; Nishizaki K
    Allergy; 2001 Jun; 56(6):525-31. PubMed ID: 11421897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.